A Study in the United Sates That Looks at the Safety and Effectiveness of Pradaxa Pellets in Children Aged 3 Months to Less Than 12 Years Who Need Treatment of a Blood Clot or Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot

NCT05966740 · clinicaltrials.gov ↗

TERMINATED

Status

6

Enrollment

INDUSTRY

Sponsor class

Stopped Low study enrolment.

Conditions

Venous Thromboembolism

Sponsor

Boehringer Ingelheim

Collaborators

[object Object]